Not currently recruiting at University of California Health
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
Summary
- Eligibility
- for people ages 1-25 (full criteria)
- Location
- at UCLA UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by William May (ucla)Michelle Hermiston (ucsf)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientists at University of California Health
- William May (ucla)
- Michelle Hermiston (ucsf)
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 152 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT03876769
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 121 study participants
- Last Updated